Neutral impactIPO

Navi Nifty MidSmallcap 400 Index Fund(G)-Direct Plan

Univest 7 hrs ago·17 Sept 2026, 10:25 am

The Navi Nifty MidSmallcap 400 Index Fund (G) is a new investment option that tracks the performance of the Nifty MidSmallcap 400 index. This benchmark includes 400 companies listed on Indian exchanges, selected to represent the mid and small-cap segments of the market. By investing in this fund, you are essentially buying a basket of stocks that mirrors the overall performance of these smaller and mid-sized companies.

For investors, this fund offers a way to gain exposure to the mid and small-cap segments without having to pick individual stocks. These segments often show higher growth potential compared to large-cap stocks, but they also come with higher volatility. This fund provides a diversified approach, spreading risk across 400 different companies rather than concentrating it in a few.

What to watch next includes the fund's expense ratio, which will determine its ongoing costs, and the fund's performance once it starts trading. Investors should also consider their own risk tolerance, as mid and small-cap stocks can be more volatile than large-cap stocks. It is important to review the fund's prospectus for details on its investment strategy and risks.

Excerpt from Univest

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mattis eget etiam curabitur a cras malesuada pulvinar. Unlock our SEBI-RIA verdict on this fund. Exit load, stamp duty and tax Stamp duty on investment: 0.005% (from July 1st, 2020) If you redeem within less than 1 year, returns are taxed as per your Income Tax…
Read the original at Univest

Key takeaways

  • Category: IPO.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Univest.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.